Drugmakers Seek Clarity on Guidance on Use of Placebo and Blinding in Oncology Trials

Drugmakers Seek Clarity on Guidance on Use of Placebo and Blinding in Oncology Trials

Source: 
RAPS.org
snippet: 

A half-dozen biopharma companies are seeking further clarity from the US Food and Drug Administration (FDA) regarding draft guidance from August on using a placebo in certain oncology trials.